Synthes produces record sales and earnings

The Synthes medical device maker has reported a record 2008 financial year, with net profit up by 20 per cent to $735 million (SFr861.3 million).

This content was published on February 18, 2009

The group, which has headquarters in the Swiss city of Solothurn and West Chester, Pennsylvania, said on Wednesday that sales were up by nearly 16 per cent to $3.2 billion.

Figures at Synthes, which is listed on the Swiss stock exchange, beat market forecasts. Demand grew across all regions and product lines, the company said in a statement.

Synthes is the world's largest maker of implants to mend bone fractures and also produces surgical power tools and advanced biomaterials.

In its outlook, Synthes said sales should rise by a low double-digit percentage in local currencies this year, the same as it had targeted in 2008.

Market observers say the company has been resilient to the global economic crisis because its products are mostly part of essential treatments.

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Weekly top stories

Keep up to date with the best stories from SWI on a range of topics, straight into your mailbox.


The SBC Privacy Policy provides additional information on how your data is processed.